GJA1 and Sepsis: Furthermore, the protective effect observed in Cx43/45-deficient mice, both in terms of inflammation and muscle preservation, suggests that targeting sarcolemma Cx HCs could be a potential therapeutic strategy for mitigating sepsis-induced muscle pathology.